Liquidia Corporation (LQDA) is listed on NASDAQ in Pharmaceutical Stocks. It is $67.67, -3.25%, with a $6.1B market cap. RSI is 38.4, near oversold. The latest reported quarter missed estimates. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 38.4 Near Oversold
Market Cap $6.1B
Volume 746.1K
Fundamentals — 10-Q Q2 2026
Revenue $304.5M
Net Income $127.6M
EPS $1.26
Operating Margin 48.3%
Net Margin 41.9%
P/E Ratio 53.7x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Adair Jason | Chief Business Officer | Sell | 73,631 | $69.09 | $5.1M | 2026 Aug 21 |
| Rielly-gauvin Katherine | Director | Sell | 55,182 | $74.07 | $4.1M | 2026 Aug 20 |
| Saggar Rajeev | Chief Medical Officer | Sell | 79,534 | $75.09 | $6.0M | 2026 Aug 19 |
| Boyle Dana | Chief Accounting Officer | Sell | 1,600 | $87.53 | $140,048 | 2026 Jul 27 |
| Adair Jason | Chief Business Officer | Sell | 688 | $87.53 | $60,221 | 2026 Jul 27 |
| Bloch Stephen M | Director | Sell | 200,000 | $88.93 | $17.8M | 2026 Jul 23 |
| Bloch Stephen M | Director | Sell | 78,596 | $79.97 | $6.3M | 2026 Jul 21 |
| Krepp Sarah | Chief Human Resource Officer | Sell | 7,864 | $71.51 | $562,361 | 2026 Jul 13 |
| Khindri Sanjeev | Chief Development Officer | Sell | 1,185 | $71.51 | $84,740 | 2026 Jul 13 |
| Kaseta Michael | CFO and COO | Sell | 20,430 | $71.51 | $1.5M | 2026 Jul 13 |
| Jeffs Roger | Chief Executive Officer | Sell | 35,249 | $71.51 | $2.5M | 2026 Jul 13 |
| Adair Jason | Chief Business Officer | Sell | 7,863 | $71.51 | $562,289 | 2026 Jul 13 |
| Schundler Russell | General Counsel | Sell | 14,738 | $71.51 | $1.1M | 2026 Jul 13 |
| Saggar Rajeev | Chief Medical Officer | Sell | 9,926 | $71.51 | $709,816 | 2026 Jul 13 |
| Moomaw Scott | Chief Commercial Officer | Sell | 9,539 | $71.51 | $682,142 | 2026 Jul 13 |
| Boyle Dana | Chief Accounting Officer | Sell | 9,002 | $71.51 | $643,740 | 2026 Jul 13 |
| Bloch Stephen M | Director | Sell | 75,000 | $80.68 | $6.1M | 2026 Jul 7 |
| Bloch Stephen M | Director | Sell | 25,000 | $79.47 | $2.0M | 2026 Jul 1 |
| Bloch Stephen M | Director | Sell | 100,000 | $75.74 | $7.6M | 2026 Jun 22 |
| Bloch Stephen M | Director | Sell | 196,111 | $71.45 | $14.0M | 2026 Jun 15 |
Other Pharmaceutical Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $1,173.34 | 46.3 | $1.1T |
| | $268.01 | 58.6 | $645.9B |
| | $148.31 | 64.1 | $365.9B |
| | $59.99 | 39.6 | $5.8B |
| | $48.69 | 60.7 | $3.1B |
| | $97.41 | 36.9 | $6.3B |
Take LQDA further
- Browse Pharmaceutical Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put LQDA in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Liquidia Corporation next reports.
Set alerts on LQDA
Get notified when Liquidia Corporation hits your price targets or technical conditions are met.
Get Started Free